Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lamin | 0.0082 | 0.2954 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.2886 | 0.2816 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0098 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0239 | 1 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0098 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0406 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.148 | 0.1396 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.148 | 0.148 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0778 | 0.0686 |
Schistosoma mansoni | lamin | 0.0082 | 0.2954 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0151 | 0.6045 | 0.6006 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.1411 | 0.1326 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0048 | 0.1411 | 0.1411 |
Echinococcus granulosus | intermediate filament protein | 0.0082 | 0.2954 | 0.2884 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0048 | 0.1411 | 0.1326 |
Brugia malayi | intermediate filament protein | 0.0082 | 0.2954 | 0.2954 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.148 | 0.148 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.2954 | 0.2884 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0406 | 1 |
Echinococcus multilocularis | musashi | 0.0082 | 0.2954 | 0.2884 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0026 | 0.0406 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.1411 | 0.4598 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0044 | 0.1239 | 0.1239 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0406 | 1 |
Onchocerca volvulus | 0.0082 | 0.2954 | 1 | |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0048 | 0.1411 | 0.1326 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0044 | 0.1239 | 0.1152 |
Brugia malayi | Muscleblind-like protein | 0.0151 | 0.6045 | 0.6045 |
Loa Loa (eye worm) | intermediate filament protein | 0.0082 | 0.2954 | 0.2884 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0406 | 0.0406 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0239 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0406 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0151 | 0.6045 | 0.6006 |
Loa Loa (eye worm) | hypothetical protein | 0.0239 | 1 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0049 | 0.1451 | 0.4739 |
Onchocerca volvulus | 0.0082 | 0.2954 | 1 | |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0778 | 0.0778 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.1411 | 0.1326 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0406 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0082 | 0.2954 | 0.2954 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0082 | 0.2954 | 0.2884 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0778 | 0.2381 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0098 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.1043 | 0.0954 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0406 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0151 | 0.6045 | 0.6006 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0975 | 0.0886 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.1411 | 0.4598 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.148 | 0.1396 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0098 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0975 | 0.0886 |
Echinococcus granulosus | lamin | 0.0082 | 0.2954 | 0.2884 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.004 | 0.1043 | 0.0954 |
Echinococcus multilocularis | lamin dm0 | 0.0082 | 0.2954 | 0.2884 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0098 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0098 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0048 | 0.1411 | 0.1326 |
Echinococcus granulosus | lamin dm0 | 0.0082 | 0.2954 | 0.2884 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0098 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0049 | 0.1451 | 0.1451 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0406 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0098 | 0.0098 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0098 | 0.5 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.004 | 0.1043 | 0.0954 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0048 | 0.1411 | 0.4598 |
Schistosoma mansoni | intermediate filament proteins | 0.0082 | 0.2954 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.1451 | 0.4739 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0406 | 0.0311 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.6045 | 0.6006 |
Echinococcus multilocularis | lamin | 0.0082 | 0.2954 | 0.2884 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.6045 | 0.6006 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.